These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35822403)

  • 21. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.
    Bunn SK; Bisset WM; Main MJ; Golden BE
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):171-7. PubMed ID: 11321388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
    Bunn SK; Bisset WM; Main MJ; Gray ES; Olson S; Golden BE
    J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):14-22. PubMed ID: 11479402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease.
    Thorsvik S; Damås JK; Granlund AV; Flo TH; Bergh K; Østvik AE; Sandvik AK
    J Gastroenterol Hepatol; 2017 Jan; 32(1):128-135. PubMed ID: 27640344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy.
    Egea-Valenzuela J; Alberca-de-Las-Parras F; Carballo-Álvarez F
    Rev Esp Enferm Dig; 2015 Apr; 107(4):211-4. PubMed ID: 25824919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients.
    Pedersen L; Nybo M; Poulsen MK; Henriksen JE; Dahl J; Rasmussen LM
    BMC Cardiovasc Disord; 2014 Dec; 14():196. PubMed ID: 25527236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analytical and clinical evaluation of DiaSorin Liaison® Calprotectin fecal assay adapted for serum samples.
    Macias-Muñoz L; Frade-Sosa B; Iniciarte-Mundo J; Hidalgo S; Morla RM; Gallegos Y; Sanmarti R; Auge JM
    J Clin Lab Anal; 2022 Mar; 36(3):e24258. PubMed ID: 35122317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease.
    De Sloovere MMW; De Smet D; Baert FJ; Debrabandere J; Vanpoucke HJM
    Clin Chem Lab Med; 2017 Aug; 55(9):1435-1446. PubMed ID: 28076305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Fecal Calprotectin Combined With Stool Hemoglobin in Differentiating Bacterial Origin in Acute Gastroenteritis.
    Kim HJ
    Pediatr Emerg Care; 2022 Feb; 38(2):e670-e673. PubMed ID: 35100765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is canine calprotectin in serum stabile after storage at low temperature?
    Kostanjšak T; Bojanić K; Čičak H; Gotić J; Vrbanac Z; Šimundić AM; Vnuk D; Bottegaro NB
    BMC Vet Res; 2022 Dec; 18(1):451. PubMed ID: 36564781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
    Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
    Sidler MA; Leach ST; Day AS
    Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
    Sydora MJ; Sydora BC; Fedorak RN
    J Crohns Colitis; 2012 Mar; 6(2):207-14. PubMed ID: 22325175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability.
    Padoan A; D'Incà R; Scapellato ML; De Bastiani R; Caccaro R; Mescoli C; Moz S; Bozzato D; Zambon CF; Lorenzon G; Rugge M; Plebani M; Basso D
    Clin Chem Lab Med; 2018 Oct; 56(11):1926-1935. PubMed ID: 29729144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calprotectin, an available prognostic biomarker in systemic sclerosis: a systematic review.
    Ebrahimi B; Nazarinia M; Molayem M
    Clin Rheumatol; 2021 May; 40(5):1709-1715. PubMed ID: 33044726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review.
    Kostakis ID; Cholidou KG; Vaiopoulos AG; Vlachos IS; Perrea D; Vaos G
    Dig Dis Sci; 2013 Feb; 58(2):309-19. PubMed ID: 22899243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive Correlation of Fecal Calprotectin With Serum Antioxidant Enzymes in Patients With Inflammatory Bowel Disease: Accidental Numerical Correlation or a New Finding?
    Vaghari-Tabari M; Moein S; Qujeq D; Kashifard M; Hajian-Tilaki K
    Am J Med Sci; 2018 May; 355(5):449-455. PubMed ID: 29753375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease.
    Gauss A; Geiss T; Hinz U; Schaefert R; Zwickel P; Zawierucha A; Stremmel W; Klute L
    Medicine (Baltimore); 2016 Apr; 95(16):e3477. PubMed ID: 27100452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
    Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.